- 5-DBFPV
- 3-Desoxy-MDPV
- 5-Dihydrobenzofuranpyrovalerone
Kaizaki-Mitsumoto, A; Noguchi, N; Yamaguchi, S; Odanaka, Y; Matsubayashi, S; Kumamoto, H; Fukuhara, K; Funada, M; Wada, K; Numazawa, S. Three 25-NBOMe-type drugs, three other phenethylamine-type drugs (25I-NBMD, RH34, and escaline), eight cathinone derivatives, and a phencyclidine analog MMXE, newly identified in ingredients of drug products before they were sold on the drug market Forensic Toxicol., 1 Jan 2016, 34 (1), 108–114. 854 kB. https://doi.org/10.1007/s11419-015-0293-6 #7 MS,NMR
EMCDDA. New drugs in Europe, 2015, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 May 2016. 1.0 MB. #12
Qian, Z; Jia, W; Li, T; Hua, Z; Liu, C. Identification of five pyrrolidinyl substituted cathinones and the collision-induced dissociation of electrospray-generated pyrrolidinyl substituted cathinones: Identification of five pyrrolidinyl substituted cathinones Drug Test. Anal., 1 May 2017, 9 (5), 778-787. 978 kB. https://doi.org/10.1002/dta.2035 #4 LC,MS,NMR
Sasaki, R; Kato, M; Matsumoto, T; Udagawa, A; Matsuzaki, R. A method for identifying designer drugs of synthetic cathinones JCCL, 1 Dec 2015, (55), 17–41. 663 kB. #19 Japanese, English abstract MS,NMR,IR,UV
Hägele, JS; Basrak, M; Schmid, MG. Enantioselective separation of novel psychoactive substances using a Lux® AMP 3 μm column and HPLC-UV J. Pharm. Biomed. Anal., 5 Feb 2020, 179, 112967. 3.6 MB. https://doi.org/10.1016/j.jpba.2019.112967 #R LC